IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.720
-0.020 (-1.15%)
At close: Mar 6, 2026, 4:00 PM EST
1.730
+0.010 (0.58%)
After-hours: Mar 6, 2026, 5:26 PM EST

IN8bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
10.6911.1221.2818.1837.0217.99
Cash & Short-Term Investments
10.6911.1221.2818.1837.0217.99
Cash Growth
167.16%-47.75%17.05%-50.89%105.74%2849.84%
Other Current Assets
1.081.463.344.051.960.15
Total Current Assets
11.7712.5824.6322.2338.9818.14
Net Property, Plant & Equipment
4.567.838.5710.32.830.19
Other Long-Term Assets
0.440.540.510.510.412.58
Total Assets
16.7720.9433.7133.0442.2220.91
Accounts Payable
0.20.390.922.090.40.62
Accrued Expenses
0.421.052.962.341.241.78
Short-Term Debt
-----0.17
Current Portion of Leases
1.081.651.511.390.63-
Total Current Liabilities
1.73.085.395.822.262.57
Long-Term Leases
1.883.383.384.491.78-
Other Long-Term Liabilities
-----0.02
Total Long-Term Liabilities
1.883.383.384.491.780.02
Total Liabilities
3.586.478.7710.314.042.59
Common Stock
0.010.010000
Additional Paid-in Capital
149.33136.13116.1583.9470.871.46
Retained Earnings
-136.15-121.66-91.22-61.21-32.69-18.04
Total Common Shareholders' Equity
13.1914.4824.9422.7338.18-16.58
Minority Interest
-----34.9
Shareholders' Equity
13.1914.4824.9422.7338.1818.32
Total Liabilities & Equity
16.7720.9433.7133.0442.2220.91
Total Debt
2.965.034.895.872.410.17
Net Cash (Debt)
7.736.0916.3912.3134.6117.82
Net Cash Growth
26.96%-62.84%33.16%-64.44%94.23%2821.31%
Net Cash Per Share
2.203.4116.4617.61104.15156.36
Book Value
13.1914.4824.9422.7338.18-16.58
Book Value Per Share
3.768.1125.0532.52114.90-145.47
Tangible Book Value
13.1914.4824.9422.7338.18-16.58
Tangible Book Value Per Share
3.768.1125.0532.52114.90-145.47
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q